- Email: [email protected]
- Telephone: +1 617 428 7022
- Fax: +1 617 428 7045
- Website: http://www.clarkelbing.com
Partner at Clark+Elbing LLP
A partner at Clark+Elbing, Jeffrey Ellison advises clients on a wide range of patent-related matters, including the preparation and prosecution of patent applications; management of complex patent portfolios; analysis of patent validity, enforceability and infringement issues; drafting of patent licences and other agreements concerning the development and/or transfer of technology; and IP due diligence for venture capital investments, mergers and acquisitions, and licensing opportunities.
Mr Ellison is well versed in patent portfolio management, the interplay of intellectual property with Food and Drug Administration (FDA) regulatory matters, and the evaluation and protection of business plans involving FDA-approved products. Mr Ellison’s practice emphasises inventions in various areas of technology, including pharmaceuticals, drug delivery systems, polymers and medical devices.
Mr Ellison has given numerous presentations about IP issues of specific interest to the protection of FDA-approved products. These presentations typically emphasised the statutory requirements for the approval of generic drugs and biologics, and the resulting implications for patent drafting, patent prosecution and the valuation of various types of patent claims. Other topics included the relevance of the Doctrine of Equivalents to the protection of certain classes of FDA-approved products.
Mr Ellison worked as a chemist in the pharmaceutical field prior to joining Clark+Elbing over 19 years ago.